Guido Torzilli

Last updated
Guido Torzilli
Born
Guido Torzilli

(1962-11-29) 29 November 1962 (age 60)
Medical career
Profession Surgeon
InstitutionsUniversity of Milan
University of Tokyo
Humanitas research hospital
Sub-specialties Hepatobiliary surgery

Guido Torzilli is an Italian liver surgeon from Milan, known for his surgical and scientific activities in the field of precision surgery for malignant liver tumors.

Contents

Education and career

Torzilli was admitted to the Medical Faculty of the University of Milan and completed his studies with the predicate summa cum laude. In the following years, he specialized in General Surgery at the same institution until 1993. For his PhD Program he moved to Japan, at the University of Tokyo, as a fellow of the Japanese Foundation for Promotion of Cancer Research. There he reached the position of assistant professor. After four years in the hepatobiliary surgical unit of the Hospital of Lodi, he returned to his Alma mater und became head of the Liver Surgery Section at the University of Milan. During this time he was also active in Radiology Education for Residents at the University of Pavia and in several other medical specialties in other Italian universities. Since 2006 he has been leading the Liver Surgery Department of the Humanitas Research Hospital. [1]

Scientific and surgical activities

Torzilli had published more than 200 scientific articles, had edited two books and had written more than 50 chapters in medical books (2016). [1] According to Google Scholar, in 2020 his publications has been cited 11,624 times. [2] His interest in intraoperative ultrasound examination of the liver and its vascular structures led to the development of several novel techniques, such as liver tunneling, minimesohepatectomy and the upper transverse liver resection. [3] [4] [5] He has been driven be the conviction, that a tailored liver surgery for malignant tumors should have the secondary goal of sparing parenchymal volume as well as the vascular skeleton of the liver. The overall strategy he dedicated much of his research and surgical activities to, has become known as parenchymal sparing liver surgery.[ citation needed ]

Related Research Articles

<span class="mw-page-title-main">Penectomy</span> Medical removal of the penis

Penectomy is penis removal through surgery, generally for medical or personal reasons.

<span class="mw-page-title-main">Mastectomy</span> Surgical removal of one or both breasts

Mastectomy is the medical term for the surgical removal of one or both breasts, partially or completely. A mastectomy is usually carried out to treat breast cancer. In some cases, women believed to be at high risk of breast cancer have the operation as a preventive measure. Alternatively, some women can choose to have a wide local excision, also known as a lumpectomy, an operation in which a small volume of breast tissue containing the tumor and a surrounding margin of healthy tissue is removed to conserve the breast. Both mastectomy and lumpectomy are referred to as "local therapies" for breast cancer, targeting the area of the tumor, as opposed to systemic therapies, such as chemotherapy, hormonal therapy, or immunotherapy.

<span class="mw-page-title-main">Gastrointestinal stromal tumor</span> Human disease (cancer)

Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. GISTs arise in the smooth muscle pacemaker interstitial cell of Cajal, or similar cells. They are defined as tumors whose behavior is driven by mutations in the KIT gene (85%), PDGFRA gene (10%), or BRAF kinase (rare). 95% of GISTs stain positively for KIT (CD117). Most (66%) occur in the stomach and gastric GISTs have a lower malignant potential than tumors found elsewhere in the GI tract.

<span class="mw-page-title-main">Klatskin tumor</span> Medical condition

A Klatskin tumor is a cholangiocarcinoma occurring at the confluence of the right and left hepatic bile ducts. The disease was named after Gerald Klatskin, who in 1965 described 15 cases and found some characteristics for this type of cholangiocarcinoma

<span class="mw-page-title-main">Gastrectomy</span> Surgical removal of the stomach

A gastrectomy is a partial or total surgical removal of the stomach.

<span class="mw-page-title-main">Cholangiocarcinoma</span> Bile duct adenocarcinoma

Cholangiocarcinoma, also known as bile duct cancer, is a type of cancer that forms in the bile ducts. Symptoms of cholangiocarcinoma may include abdominal pain, yellowish skin, weight loss, generalized itching, and fever. Light colored stool or dark urine may also occur. Other biliary tract cancers include gallbladder cancer and cancer of the ampulla of Vater.

<span class="mw-page-title-main">Pancreaticoduodenectomy</span> Major surgical procedure involving the pancreas, duodenum, and other organs

A pancreaticoduodenectomy, also known as a Whipple procedure, is a major surgical operation most often performed to remove cancerous tumours from the head of the pancreas. It is also used for the treatment of pancreatic or duodenal trauma, or chronic pancreatitis. Due to the shared blood supply of organs in the proximal gastrointestinal system, surgical removal of the head of the pancreas also necessitates removal of the duodenum, proximal jejunum, gallbladder, and, occasionally, part of the stomach.

<span class="mw-page-title-main">Pseudomyxoma peritonei</span> Medical condition

Pseudomyxoma peritonei (PMP) is a clinical condition caused by cancerous cells that produce abundant mucin or gelatinous ascites. The tumors cause fibrosis of tissues and impede digestion or organ function, and if left untreated, the tumors and mucin they produce will fill the abdominal cavity. This will result in compression of organs and will destroy the function of the colon, small intestine, stomach, or other organs. Prognosis with treatment in many cases is optimistic, but the disease is lethal if untreated, with death occurring via cachexia, bowel obstruction, or other types of complications.

<span class="mw-page-title-main">Duodenal cancer</span> Medical condition

Duodenal cancer is a cancer in the first section of the small intestine known as the duodenum. Cancer of the duodenum is relatively rare compared to stomach cancer and colorectal cancer. Its histology is usually adenocarcinoma.

Hepatectomy is the surgical resection of the liver. While the term is often employed for the removal of the liver from a liver transplant donor, this article will focus on partial resections of hepatic tissue and hepatoportoenterostomy.

<span class="mw-page-title-main">Hepatic lymph nodes</span> Lymph nodes on the common hepatic artery

The hepatic lymph nodes consist of the following groups:

Hepatic arterial infusion (HAI) is a medical procedure that delivers chemotherapy directly to the liver. The procedure, mostly used in combination with systemic chemotherapy, plays a role in the treatment of liver metastases in patients with colorectal cancer (CRC). Although surgical resection remains the standard of care for these liver metastases, majority of patients have lesions that are unresectable.

<span class="mw-page-title-main">Peritoneal mesothelioma</span> Medical condition

Peritoneal mesothelioma is the name given to the cancer that attacks the lining of the abdomen. This type of cancer affects the lining that protects the contents of the abdomen and which also provides a lubricating fluid to enable the organs to move and work properly.

<span class="mw-page-title-main">David Geller</span> American surgeon

Dr. David Geller is the Richard L. Simmons Professor of Surgery at the University of Pittsburgh School of Medicine, and co-director of the UPMC Liver Cancer Center. As a hepatobiliary Surgical Oncologist, his clinical interests center on the evaluation and management of patients with liver cancer. He has pioneered laparoscopic liver resections, and has performed more than 300 of these cases. Most of these patients are discharged home on the second post-operative day with four to five band-aid-sized incisions. He also specializes in performing laparoscopic radiofrequency ablations of liver tumors. Dr. Geller is a member of many professional and scientific societies including the American Surgical Association, Society of Surgical Oncology, Society of University Surgeons, and the American Society of Transplant Surgeons.

Irreversible electroporation is a soft tissue ablation technique using short but strong electrical fields to create permanent and hence lethal nanopores in the cell membrane, to disrupt cellular homeostasis. The resulting cell death results from induced apoptosis or necrosis induced by either membrane disruption or secondary breakdown of the membrane due to transmembrane transfer of electrolytes and adenosine triphosphate. The main use of IRE lies in tumor ablation in regions where precision and conservation of the extracellular matrix, blood flow and nerves are of importance. The first generation of IRE for clinical use, in the form of the NanoKnife System, became commercially available for research purposes in 2009, solely for the surgical ablation of soft tissue tumors. Cancerous tissue ablation via IRE appears to show significant cancer specific immunological responses which are currently being evaluated alone and in combination with cancer immunotherapy.

A small intestine neuroendocrine tumor is a carcinoid in the distal small intestine or the proximal large intestine. It is a relatively rare cancer and is diagnosed in approximately 1/100000 people every year. In recent decades the incidence has increased. The prognosis is comparatively good with a median survival of more than 8 years. The disease was named by Siegfried Oberndorfer, a German pathologist, in 1907.

<span class="mw-page-title-main">Herbert Snow</span> English surgeon and medical writer

Herbert Lumley Snow was an English surgeon, anti-vivisectionist, cancer researcher and medical writer.

Andrea A. Hayes Dixon is an American surgeon. She was the first pediatric surgeon to perform a high-risk, life-saving procedure in children with a rare form of cancer and developed the first orthotropic xenograft model of metastatic Ewing's sarcoma. In 2002, she became the first African American female pediatric surgeon board-certified in the United States.

Myxofibrosarcoma (MFS), although a rare type of tumor, is one of the most common soft tissue sarcomas, i.e. cancerous tumors, that develop in the soft tissues of elderly individuals. Initially considered to be a type of histiocytoma termed fibrous histiocytoma or myxoid variant of malignant fibrous histiocytoma, Angervall et al. termed this tumor myxofibrosarcoma in 1977. In 2020, the World Health Organization reclassified MFS as a separate and distinct tumor in the category of malignant fibroblastic and myofibroblastic tumors.

<span class="mw-page-title-main">R. Lee Clark</span>

R. Lee Clark was a surgical oncologist and the first permanent director of MD Anderson Cancer Center.

References

  1. 1 2 "Curriculum Vitae of Guido Torzilli" (PDF).
  2. "Guido Torzilli, MD, PhD, FACS". scholar.google.com. 14 January 2020. Retrieved 14 January 2020.
  3. Torzilli, Guido; Procopio, Fabio; Viganò, Luca; Costa, Guido; Fontana, Andrea; Cimino, Matteo; Donadon, Matteo; Del Fabbro, Daniele (2019). "The Liver Tunnel". Annals of Surgery. 269 (2): 331–336. doi:10.1097/SLA.0000000000002509. ISSN   0003-4932.
  4. Torzilli, Guido; Botea, Florin; Donadon, Matteo; Cimino, Matteo; Del Fabbro, Daniele; Palmisano, Angela (2009). "Minimesohepatectomy for Colorectal Liver Metastasis Invading the Middle Hepatic Vein at the Hepatocaval Confluence". Annals of Surgical Oncology. 17 (2): 483–483. doi: 10.1245/s10434-009-0728-6 . ISSN   1068-9265.
  5. Torzilli, Guido; Procopio, Fabio; Donadon, Matteo; Del Fabbro, Daniele; Cimino, Matteo; Garcia-Etienne, Carlos A.; Montorsi, Marco (2012). "Upper Transversal Hepatectomy". Annals of Surgical Oncology. 19 (11): 3566–3566. doi: 10.1245/s10434-012-2596-8 . ISSN   1068-9265.